Boucher Brent J. 4
4 · ANGIODYNAMICS INC · Filed Oct 18, 2019
Insider Transaction Report
Form 4
Boucher Brent J.
SVP and GM of Oncology
Transactions
- Award
Performance Right
2019-10-16+6,452→ 6,452 total→ Common Stock (6,452 underlying)
Footnotes (1)
- [F1]Each performance right represents a contingent right to receive one share of common stock ("Common Stock") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited.